Retra Life Science Pvt Ltd
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimicer MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Glimicer MV 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimicer MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimicer MV 1mg/500mg/0.2mg Tablet.
Glimicer MV 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimicer MV 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimicer MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimicer MV 1mg/500mg/0.2mg Tablet is a combination medication containing Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, Metformin lowers glucose production in the liver and improves insulin sensitivity, and Voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM.
Common side effects of Glimicer MV 1mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any of these symptoms, consult your doctor or healthcare professional.
Glimicer MV 1mg/500mg/0.2mg Tablet should be avoided in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor or healthcare professional before taking this medication if you have any of these conditions.
No, it is not recommended to take Glimicer MV 1mg/500mg/0.2mg Tablet with alcohol. This combination may increase the risk of hypoglycemia and lactic acidosis. Avoid consuming alcohol while taking this medication.
Yes, Glimicer MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely to occur if you miss or delay meals, drink alcohol, over-exercise, or take other antidiabetic medications. Regularly monitor your blood sugar levels and always keep glucose tablets, honey, or fruit juice with you.
Store Glimicer MV 1mg/500mg/0.2mg Tablet in its original packaging, tightly closed. Follow the storage instructions provided on the packaging or label. Dispose of any unused medication properly, ensuring it is not consumed by pets, children, or other individuals.